Ventyx Biosciences Inc. Gains 64.98%

Mon, Sep 12, 2022 at 07:39 PM

Ventyx Biosciences Inc. (VTYX:NASDAQ) shot up at $38.11, a gain of 65%. On Mon, Sep 12, 2022, VTYX:NASDAQ hit a New 2-Week High of $38.11. The stock appeared on our News Catalysts scanner on Mon, Aug 29, 2022 at 05:49 PM in the 'MISCELLANEOUS' category. From Mon, Aug 29, 2022, the stock recorded 44.44% Up Days and 40.00% Green Days

About Ventyx Biosciences Inc. (VTYX:NASDAQ)

Ventyx Biosciences Inc is a clinical-stage biopharmaceutical company focused on advancing new therapies for millions of patients living with inflammatory diseases and autoimmune disorders.

Top 10 Gainers:

NeuroBo Pharmaceuticals, Inc. (NRBO:NASDAQ), 101.3%
InMed Pharmaceuticals Inc. (INM:NASDAQ), 70.42%
Ventyx Biosciences Inc. (VTYX:NASDAQ), 64.98%
PolyPid Ltd. (PYPD:NASDAQ), 58.33%
Arqit Quantum Inc. (ARQQ:NASDAQ), 38.1%
PaxMedica Inc. (PXMD:NASDAQ), 36.59%
IDEAYA Biosciences, Inc. (IDYA:NASDAQ), 30.7%
Clovis Oncology, Inc. (CLVS:NASDAQ), 30.43%
Kaspien Holdings Inc. (KSPN:NASDAQ), 27.68%
IHS Holding Limited (IHS:NYSE), 24.88%